Suchergebnisse - "Gulbrandsen, Nina"

PubPharm (6)

1

Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Sonneveld, P. | Dimopoulos, M. | Beksac, M. | +37

2

Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

enthalten in: Annals of hematology | 2020

von Kaiser, M. | Beksaç, M. | Gulbrandsen, N. | +14

ErratumIn: Ann Hematol. 2021 Jan;100(1):297-302. - PMID 33106909

3

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma : a randomized study

enthalten in: European journal of haematology | 2012

von Hjorth, M. | Hjertner, �. | Knudsen, L. | +47

4

Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions

enthalten in: European journal of haematology | 2011

von Nilsson-Ehle, H. | Birgegård, G. | Samuelsson, J. | +11

5

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

enthalten in: Blood | 2010

von Waage, A. | Gimsing, P. | Fayers, P. | +23

CommentIn: Blood. 2010 Sep 2;116(9):1390-1. - PMID 20813903

6

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor : significant effects on quality of life

enthalten in: British journal of haematology | 2003

von Hellström-Lindberg, E. | Gulbrandsen, N. | Lindberg, G. | +18

1
[1]